Teachers Advisors LLC Acquires 5426 Shares of Esperion Therapeutics (NASDAQ:ESPR)

The stock increased 0.74% or $2.47 during the last trading session, reaching $335.17. About 374,813 shares traded.

BB&T Securities LLC bought a new stake in Esperion Therapeutics (NASDAQ:ESPR) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. ESPR outperformed the S&P500 by 78.31%. It was reported on April, 18 by Finviz.com. We have $84.70 PT which if reached, will make NASDAQ:ESPR worth $185.31M more.

Among 2 analysts covering Twenty-First Century Fox (NASDAQ:FOX), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. (NASDAQ:ESPR) has "Buy" rating given by Jefferies. Six investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Geode Capital Mngmt Ltd Liability Corporation has invested 0% of its portfolio in Esperion Therapeutics, Inc. The stock of Silicon Motion Technology Corporation (NASDAQ:SIMO) has "Outperform" rating given on Monday, August 17 by Pacific Crest. (NYSE:YELP) rating on Friday, February 10. The firm has "Sell" rating by Deutsche Bank given on Monday, February 22. Back-tests of such patterns show that the break even failure rate is 10%, the average rise: 19%, the throwback rate: 61% and the percentage of stocks meeting their price targets: 40%. The firm has "Buy" rating by RBC Capital Markets given on Tuesday, January 9. The company was maintained on Wednesday, July 29 by Brean Capital. The stock of Express Scripts Holding Company (NASDAQ:ESRX) earned "Market Perform" rating by Bernstein on Wednesday, December 6.

The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). The stock's market capitalization is $827.54 million. Its lead product candidate is bempedoic acid/ezetimibe combination pill, a non-statin, orally available, LDL-C lowering therapy for patients with hypercholesterolemia and with atherosclerotic cardiovascular disease, and/or heterozygous familial hypercholesterolemia that is in Phase III long-term safety and tolerability study. It now has negative earnings. Finally, American International Group Inc. boosted its holdings in shares of Esperion Therapeutics by 21.6% in the 3rd quarter. Following the sale, the director now owns 3,177 shares of the company's stock, valued at $228,076.83. During the same quarter in the prior year, the company earned ($0.58) EPS. The institutional investor held 2.32 million shares of the health care company at the end of 2017Q4, valued at $152.94 million, up from 2.29M at the end of the previous reported quarter. Tower Semiconductor Ltd. (NASDAQ:TSEM) has risen 18.08% since April 19, 2017 and is uptrending. Therefore 56% are positive. Yelp has $55.0 highest and $17 lowest target.

Sirius XM Holdings Inc. (SIRI) stock surged 16.91% during past quarter
After $0.05 actual EPS reported by Sirius XM Holdings Inc . for the previous quarter, Wall Street now forecasts 0.00% EPS growth . Following the completion of the sale, the vice president now owns 551,815 shares of the company's stock, valued at $3,371,589.65.

After Meesha Shafi, More Females Allege The Singer Of Sexual Harassment
Denying about taking sides, Actor Maya Ali has shared, she respects Ali for the person he is and wishes for the truth to come out. She continued by saying that the whole issue is about the relationship of trust that men take too casually with women.

Alia Bhatt nervous for Soni Razdan on the sets of 'Raazi'
For the music launch of Raazi , Alia Bhatt was spotted wearing this elegant Manish Malhotra piece in a lovely grey-blue colour. The Badrinath Ki Dulhania actress was snapped in a blue polka dotted top and a pair of ripped denims with grey sneakers.

Yelp Inc. (YELP) formed multiple top with $47.02 target or 4.00% above today's $45.21 share price. Since October 18, 2017 according to StockzIntelligence Inc Esperion has 17 analyst reports. Clarksons Platou downgraded the stock to "Neutral" rating in Wednesday, November 1 report. The rating was maintained by Chardan Capital Markets on Tuesday, March 27 with "Neutral". The firm earned "Buy" rating on Wednesday, February 21 by Needham. The firm has "Buy" rating given on Wednesday, November 22 by Northland Capital. On Monday, March 19 the stock rating was maintained by Jefferies with "Buy". Chardan Capital raised their price objective on Esperion Therapeutics from $75.00 to $100.00 and gave the stock a "neutral" rating in a report on Tuesday, March 27th. (NASDAQ:NFLX) on Tuesday, February 13. Cowen & Co has "Buy" rating and $9500 target. (NASDAQ:ESPR) rating on Wednesday, June 29. Esperion Therapeutics has a consensus rating of "Buy" and a consensus price target of $33.39. The firm has "Hold" rating by Mizuho given on Wednesday, January 24.

Investors sentiment decreased to 1.33 in Q4 2017. It has change of 0.34, from 2017Q3's 1.67. It dived, as 19 investors sold Esperion Therapeutics, Inc. shares while 39 reduced holdings. Iron Ltd Company accumulated 12,311 shares or 0.15% of the stock. Its stake in Rockwell Collins Inc (NYSE:COL) was upped by 180,000 shares to 3.40M shares valued at $461.11 million in 2017Q4, according to the filing. Principal Fin Inc holds 0.01% or 2.39M shares. New York-based J Goldman & Ltd Partnership has invested 0.05% in Esperion Therapeutics, Inc. Ubs Asset Management Americas holds 65,294 shares. Qci Asset Management New York reported 10,226 shares or 0.02% of all its holdings. Bancorporation Of America Corp De has invested 0% in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Pictet Asset Management holds 343,393 shares. Trust Of Vermont reported 0% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Bb Biotech Ag holds 2.36M shares or 4.38% of its portfolio. Old Mutual Customised Solutions (Proprietary) Ltd holds 7,300 shares or 0% of its portfolio. Guggenheim Limited Company holds 39,528 shares. Finally, Virtus Fund Advisers LLC acquired a new stake in Esperion Therapeutics in the fourth quarter valued at $399,000.

TRADEMARK VIOLATION WARNING: "Esperion Therapeutics (ESPR) Getting Somewhat Positive Press Coverage, Report Shows" was reported by Enterprise Leader and is owned by of Enterprise Leader. Jasper Ridge Prns L P holds 0.04% of its portfolio in Esperion Therapeutics, Inc. Ascend Cap Limited Liability Corporation owns 67,241 shares. 56,000 were reported by Atika Cap Mngmt Limited Company.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.